
AstraZeneca PLC (AZN) P/E Ratio
P/E Ratio as of Feb 2, 2026: 31.08
Average58.56
Median61.82
Minimum30.60
Maximum63.49
31.08
29.26 (48.49%)past month
The P/E ratio for AstraZeneca PLC (AZN) is 31.08 as of Feb 2, 2026. This represents a decrease of -46.05% compared to its 12-month average P/E ratio of 57.61. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
AstraZeneca PLC P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
AstraZeneca PLC’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing AstraZeneca PLC to industry peers.
AstraZeneca PLC P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
AstraZeneca PLC’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing AstraZeneca PLC to industry peers.
AstraZeneca PLC (AZN) P/E Ratio Insights
See AstraZeneca PLC’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in AstraZeneca PLC (AZN)
Order type
Buy in
Order amount
Est. shares
0 shares
AstraZeneca PLC (AZN) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Dec 1, 2025 | $181.04 | 59.65 |
| Nov 3, 2025 | $163.44 | 60.89 |
| Oct 1, 2025 | $168.72 | 62.85 |
| Sep 2, 2025 | $160.38 | 59.75 |
| Aug 1, 2025 | $147.90 | 55.10 |
| Jul 1, 2025 | $142.92 | 57.01 |
| Jun 2, 2025 | $143.86 | 57.38 |
| May 1, 2025 | $141.02 | 56.25 |
| Apr 1, 2025 | $145.20 | 63.97 |
| Mar 3, 2025 | $152.20 | 67.05 |
| Feb 3, 2025 | $139.72 | 61.56 |
| Jan 2, 2025 | $131.76 | 62.87 |
AstraZeneca PLC (AZN) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | 31.08 | -48.70% |
| 2025 | 60.58 | -3.12% |
| 2024 | 62.53 | -11.67% |
| 2023 | 70.79 | -65.63% |
| 2022 | 205.95 | -75.22% |
| 2021 | 830.96 | — |
FAQs About AstraZeneca PLC (AZN) P/E ratio
The latest P/E ratio of AstraZeneca PLC (AZN) is 31.08, as of Feb 2, 2026. This is calculated based on its current stock price and earnings per share (EPS).
AstraZeneca PLC’s last 12-month average P/E ratio is 57.61, compared to its current P/E ratio of 31.08. This reflects a decrease of -46.05%.
AstraZeneca PLC’s current P/E ratio of 31.08 is lower than its last 12-month average P/E of 57.61. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
AstraZeneca PLC’s average P/E ratio over the last 3 years is 69.54. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
AstraZeneca PLC’s average P/E ratio over the last 5 years is 80.16. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.